To Ocugen CEO Shankar Musunuri, Ph.D., most gene therapy biotechs today lack vision. | Many gene therapy outfits focus on ...
Starting up in a garage isn’t an option for life sciences companies that do things like analyze microbes and test saliva samples. They need laboratory space, which is in short supply in Minnesota.
New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.
VCs and universities struggle with different goals and timelines, but tech transfer is helping turn academic science into ...
Takeda has pulled back from a research collaboration with a fellow Japanese life sciences company, ending work to discover ...
Houman Hemmati, a board-certified ophthalmologist, biotech executive and frequent Fox News guest, is a candidate to become ...
Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will ...
In this edition of the biotech bi-weekly, get the latest biotech industry updates, with special focus on the upcoming AACR ...
For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...
March 27 (Reuters) - Swiss drugmaker Novartis will buy California-based biotech company Excellergy in a deal worth up to $2 billion, it said on Friday, extending its anti-allergy range and in line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results